NET PROFIT (x1000 EUR)
EMPLOYEES
Hamlet BioPharma AB
Closing information (x1000 EUR)
| Closing information | 2024/06 (consolidated) | 2023/06 (consolidated) | 2022/06 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
7 |
| Earnings before taxes |
-3,681
|
-1,734
|
-1,610 |
| EBITDA |
-2,899
|
-1,700
|
-1,602 |
| Total assets |
6,036
|
2,416
|
3,907 |
| Current assets |
2,403
|
1,612
|
3,907 |
| Current liabilities |
362
|
216
|
348 |
| Equity capital |
5,674
|
1,776
|
3,559 |
| - share capital |
148
|
95
|
103 |
| Employees (average) |
7
|
4
|
4 |
Financial ratios
| Fiscal year | 2024/06 (consolidated) | 2023/06 (consolidated) | 2022/06 |
| Solvency |
94.0%
|
73.5%
|
91.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-61.0%
|
-71.8%
|
-41.0% |
| Current ratio |
663.8%
|
746.3%
|
1122.7% |
| Return on equity (ROE) |
-64.9%
|
-97.6%
|
-45.2% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
3
|
0
|
0 |
| Chg. No. of employees % | 75% | 0% |
Total value of public sale
| Fiscal year | 2024/06 (consolidated) | 2023/06 (consolidated) | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.